Status:
COMPLETED
Survey of Prostate Cancer in Accra, Ghana
Lead Sponsor:
National Cancer Institute (NCI)
Collaborating Sponsors:
National Institute on Minority Health and Health Disparities (NIMHD)
Conditions:
Prostate Cancer
Eligibility:
MALE
18-125 years
Brief Summary
This study, conducted at Korle-Bu Hospital in Accra, Ghana, will help elucidate the roles of lifestyle and genetic factors in prostate cancer risk. There is a strong variation in risk of prostate canc...
Detailed Description
OBJECTIVE: The key aim of this study is to assess the burden of prostate cancer in Ghana and to evaluate how the impact of prostate cancer among West Africans compares with that among African American...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- The 1,000 Accra residents selected for screening will include 300 men 50-59, 400 men 60-69, and 300 men 70-74 years of age.
- EXCLUSION CRITERIA:
- Men who do not meet the age requirements will be excluded from the study.
- In addition, men who have a history of prostate cancer for which they have received treatment will also be excluded (men with untreated prostate cancer will be included).
Exclusion
Key Trial Info
Start Date :
June 26 2002
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 15 2020
Estimated Enrollment :
1758 Patients enrolled
Trial Details
Trial ID
NCT00339534
Start Date
June 26 2002
End Date
May 15 2020
Last Update
May 20 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Ghana Medical-Korle Bu Teaching Hospital
Accra, Ghana